- Home
- MDGL vs CFR Comparison
MDGL vs CFR Comparison
Compare MDGL & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDGL | CFR |
|---|---|---|
| Founded | 2011 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 10.3B |
| IPO Year | 2005 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MDGL | CFR |
|---|---|---|
| Price | $519.09 | $164.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 13 |
| Target Price | ★ $674.45 | $142.31 |
| AVG Volume (30 Days) | 372.3K | ★ 585.7K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.80% |
| EPS Growth | N/A | ★ 11.84 |
| EPS | N/A | ★ 5.35 |
| Revenue | $180,133,000.00 | ★ $2,235,244,000.00 |
| Revenue This Year | $58.39 | $9.72 |
| Revenue Next Year | $48.55 | $4.70 |
| P/E Ratio | ★ N/A | $30.79 |
| Revenue Growth | N/A | ★ 8.31 |
| 52 Week Low | $393.61 | $119.00 |
| 52 Week High | $615.00 | $170.80 |
Technical Indicators
Market Signals| Indicator | MDGL | CFR |
|---|---|---|
| Relative Strength Index (RSI) | 50.90 | 52.82 |
| Support Level | $498.59 | $162.32 |
| Resistance Level | $545.13 | $170.29 |
| Average True Range (ATR) | 19.22 | 2.95 |
| MACD | 1.86 | -0.73 |
| Stochastic Oscillator | 76.90 | 32.49 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $52 billion in assets (as of March 2026), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based banking approach that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through targeted branch openings rather than acquisitions. The bank's sweet spot is small to medium-sized Texas-based commercial clients.